Stock EPWCF EMPOWER CLINICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Empower Clinics Inc. OTC Markets

Equities

EPWCF

CA29246V2030

Healthcare Facilities & Services

Delayed OTC Markets
Other stock markets
 12:09:21 2024-02-26 pm EST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Empower Clinics Inc. -.--% -.--%
Apr. 02 Empower Clinics Inc. announced that it expects to receive CAD 0.976 million in funding CI
2023 Empower Clinics Inc.'S Subsidiary EPW Curesearch LLC Signs New Agreements for Additional Pharmaceutical Research and Clinical Trials Medical Doctors with an Established Pain Management Practice and Includes Two Experienced Principal Investigators CI

Valuation

Fiscal Period: December 2018 2019 2020 2021
Capitalization 1 5.386 4.214 50.97 83.22
Enterprise Value (EV) 1 6.993 7.121 49.62 87.16
P/E ratio -1.16 x -0.77 x -2.39 x -2.49 x
Yield - - - -
Capitalization / Revenue 4.93 x 2.07 x 15.9 x 19 x
EV / Revenue 6.41 x 3.51 x 15.5 x 19.9 x
EV / EBITDA -1.66 x -2.01 x -12.8 x -17.6 x
EV / FCF -4,127,908 x -6,441,275 x 51,951,099 x -19,092,429 x
FCF Yield -0% -0% 0% -0%
Price to Book -1.81 x -1.2 x -11.6 x -13 x
Nbr of stocks (in thousands) 15,485 27,539 45,562 67,889
Reference price 2 0.3478 0.1530 1.119 1.226
Announcement Date 6/4/19 7/24/20 7/2/21 10/27/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales 1 2.135 1.507 1.091 2.032 3.209 4.369
EBITDA 1 -1.192 -2.274 -4.2 -3.55 -3.873 -4.954
EBIT 1 -1.299 -2.363 -4.309 -3.68 -4.032 -5.494
Operating Margin -60.83% -156.79% -394.85% -181.14% -125.63% -125.76%
Earnings before Tax (EBT) 1 -1.67 -3.11 -3.79 -4.302 -17.07 -31.74
Net income 1 -1.592 -3.11 -3.79 -4.302 -17.07 -32.26
Net margin -74.55% -206.36% -347.26% -211.74% -531.79% -738.31%
EPS 2 -0.7000 -0.3235 -0.3000 -0.2000 -0.4680 -0.4917
Free Cash Flow - -0.7516 -1.694 -1.106 0.9551 -4.565
FCF margin - -49.87% -155.23% -54.42% 29.76% -104.49%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/9/18 7/9/18 6/4/19 7/24/20 7/2/21 10/27/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 1.19 2.92 1.61 2.91 - 3.93
Net Cash position 1 - - - - 1.35 -
Leverage (Debt/EBITDA) -0.9969 x -1.286 x -0.3827 x -0.8191 x - -0.7938 x
Free Cash Flow - -0.75 -1.69 -1.11 0.96 -4.57
ROE (net income / shareholders' equity) - 93% 97.1% 132% 379% 534%
ROA (Net income/ Total Assets) - -250% -471% -222% -46.7% -48.1%
Assets 1 - 1.246 0.8046 1.935 36.53 67.01
Book Value Per Share 2 -0.5800 -0.5000 -0.1900 -0.1300 -0.1000 -0.0900
Cash Flow per Share 2 0 - 0.0100 0.0100 0.0900 0.0100
Capex - 0.03 0.1 0 0 2.15
Capex / Sales - 2.1% 9.18% 0.19% 0.11% 49.26%
Announcement Date 7/9/18 7/9/18 6/4/19 7/24/20 7/2/21 10/27/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.43% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.91% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.62% 29.59B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-8.89% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-1.39% 16.36B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.58% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+1.82% 11.72B
DAVITA INC. Stock DaVita Inc.
+30.89% 11.71B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-0.47% 11.66B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. EPW Stock
  4. EPWCF Stock
  5. Financials Empower Clinics Inc.